Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
QMRO Home
Barts Cancer Institute
Centre for Experimental Cancer Medicine
208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
QMRO Home
Barts Cancer Institute
Centre for Experimental Cancer Medicine
208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
Volume
32
Pagination
s449 - s450
Publisher
Elsevier
DOI
10.1016/j.annonc.2021.08.490
Journal
Annals of Oncology
ISSN
0923-7534
Metadata
Show full item record
Authors
Schmid, P; Gomez-Pardo, P; Wheatley, D; Roy, P; Krabisch, P; Thill, M; Ledwidge, S; Thompson, A; Macaskill, EJ; Viehstädt, N
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/78899
Collections
Centre for Experimental Cancer Medicine
[130]